30% incentive for substitutive dispensing proven drugs of bio-equivalency.
Published: 2001-07-05 07:00:00
Updated: 2001-07-05 07:00:00
Effective from July 1 an incentive as much as about 30% of the price balance from the upper limit insurance price will be given to pharmacies when dispensing inexpensive substitutive drug already proven of its bio-equivalency from its original product.
The MOHW decided the medication saving p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
